2Rycke L,Baeten D,Kruithof E,et al.Infliximab,but not etanercept,induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity:biologic and clinical implications in autoimmune arthritis.Arthritis Rheum,2005,52:2192-2201.
3Gibson W,Crow M,Kearns J.Kinetoplast DNA minicircles are inberited from both parents in genetic crosses of Trypanosoma brucei.Parasitol Res, 1997, 83 : 483-488.
5Flanc RS, Roberts MA, Strippoli GF, et al. Treatment of diffuse proliferative lupus nephritis : a meta-analysis of randomized controlled trials. Am J Kidney Dis, 2004, 43:197-208.
6Sekiguchil DR, Eisenberg RA, Weigert M. Second heavy chain rearrangement: a mechanism for generating anti-double stranded DNA B cell. J Exp Med, 2003, 197:27-39.
7Berden JH, Licht R, Van Bruggen MC, et al. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curt Opin Nephrol Hypertens, 1999,8:299-307.
8Chan TM, Leung JK, Ho SK, et al. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J Am Soc Nephrol, 2002, 13: 1219-1229.
9Sieling PA, Porcelli SA, Duong BT, et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol, 2000,165:5338-5344.
1Bachmaier K, Neu N, de la Maza LM, et al. Chlamydia infections and heart disease linked through antigenic mimicry. Science, 1999,283: 1335-1339.
2Deng GM, Nilsson IM, Verdrengh M, et al. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med,1999, 5: 702-705.
3Segal BM, Chang JT, Shevach EM. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J Immunol, 2000, 164: 5683-5688.
4Sacher T, Knolle P, Nichterlein T, et al. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes. Eur J Immunol, 2002, 32: 3628-3637.
5Isenberg DA, Ehrenstein MR, Longhurst C, et al. The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective. Arthritis Rheum, 1994, 37: 169-180.
6Pisetsky DS. Anti-DNA antibodies in systemic lupus erythematosus.Rheum Dis Clin North Am, 1992, 18: 437-454.
7Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 1995, 374: 546-549.
8Wasgrowska Danilewicz M, Danilewicz M. Intercellular adhesion molecule-1 (ICAM-1), leucocyte function-associated antigen-1 (LFA-1) and leucocyte infiltration in proliferative human glomerulonephritis. Acta Histochem, 1998,100(2) :201
9Kootstra CJ, Van Der Giezen DM, Van Krieken JH F, et al. Effective treatment of experimental lupus nephritis by combined administration of anti-CDlla and anti-CD54 antibodies. Clin Exp Immunol,1997,108(2) :324
6Sekiguchil DR, Eisenberg RA, Weigert M. Second heavy chain rearrangement: a mechanism for generating anti-double stranded DNA B cell. J Exp Med, 2003, 197: 27-39.
7Chan TM, Leung JK, Ho SK, et al. Mesangial cell-binding anti- DNA antibodies in patients with systemic lupus erythematosus. J Am Soc Nephrol, 2002, 13: 1219-1229.
8Bagavant H, Deshmukh U, Gaskin F, et al. Lupus glomeru- lonephritis revisited 2004: autoimmunity and end-organ damage. Scand J Immunol, 2004, 60: 52-63.
9Zhao Z, Weinstein E, Tuzova M, et al.Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum, 2005, 52: 522-530.
